Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Goodkin

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
The Nursing Clinics of North America|January 25, 2018
End-of-Life Care and Bereavement Issues in Human Immunodeficiency Virus-AIDSKarl Goodkin, Sindhura Kompella, Steven F Kendell
AIDS (London, England)|September 26, 2024
Anticholinergic and sedative medication use in persons with HIV: defining the evidence for risks on cognitionKarl Goodkin, Alan Winston, Esteban Martinez, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|June 4, 2015
Diagnostic Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Impairment and Disorder in South AfricaKarl Goodkin, David J Hardy, Dinesh Singh, et al.
Current HIV/AIDS Reports|September 22, 2017
Redefining Aging in HIV Infection Using PhenotypesDavid M Stoff, Karl Goodkin, Dilip Jeste, et al.
Journal of Neuro-Aids|July 29, 2006
Regional quantitative comparison of multispliced to unspliced ratios of HIV-1 RNA copy number in infected human brainRobert K Fujimura, Imad Khamis, Paul Shapshak, et al.
Ethnicity & Disease|February 11, 2011
A proposition against using the terms "Hispanic" and "Latino" in research on HIV-associated neurocognitive disordersEnrique López, Guadalupe Morales, Carlos Saucedo, et al.
AIDS (London, England)|January 25, 2002
The importance of cognitive self-report in early HIV-1 infection: validation of a cognitive functional status subscaleHarold M A Knippels, Karl Goodkin, Jeffrey J Weiss, et al.
Neuropsychiatry|May 18, 2013
Clinical utility of magnetic resonance spectroscopy to enhance diagnosis of HIV-associated mild neurocognitive disorderKarl Goodkin, Jeffry R Alger, Andrew A Maudsley, et al.
Frontiers in Bioscience : a Journal and Virtual Library|February 24, 2004
Elevated expression of IFN-gamma in the HIV-1 infected brainPaul Shapshak, Robert Duncan, Alireza Minagar, et al.
Thescientificworldjournal|August 28, 2018
Microglia and Astrocytes in Neuro-Aids, Alzheimers Disease, and Multiple SclerosisAlireza Minagar, Paul Shapshak, Melvin Heyes, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
The Nursing Clinics of North America|January 25, 2018
End-of-Life Care and Bereavement Issues in Human Immunodeficiency Virus-AIDSKarl Goodkin, Sindhura Kompella, Steven F Kendell
AIDS (London, England)|September 26, 2024
Anticholinergic and sedative medication use in persons with HIV: defining the evidence for risks on cognitionKarl Goodkin, Alan Winston, Esteban Martinez, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|June 4, 2015
Diagnostic Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Impairment and Disorder in South AfricaKarl Goodkin, David J Hardy, Dinesh Singh, et al.
Current HIV/AIDS Reports|September 22, 2017
Redefining Aging in HIV Infection Using PhenotypesDavid M Stoff, Karl Goodkin, Dilip Jeste, et al.
Journal of Neuro-Aids|July 29, 2006
Regional quantitative comparison of multispliced to unspliced ratios of HIV-1 RNA copy number in infected human brainRobert K Fujimura, Imad Khamis, Paul Shapshak, et al.
Ethnicity & Disease|February 11, 2011
A proposition against using the terms "Hispanic" and "Latino" in research on HIV-associated neurocognitive disordersEnrique López, Guadalupe Morales, Carlos Saucedo, et al.
AIDS (London, England)|January 25, 2002
The importance of cognitive self-report in early HIV-1 infection: validation of a cognitive functional status subscaleHarold M A Knippels, Karl Goodkin, Jeffrey J Weiss, et al.
Neuropsychiatry|May 18, 2013
Clinical utility of magnetic resonance spectroscopy to enhance diagnosis of HIV-associated mild neurocognitive disorderKarl Goodkin, Jeffry R Alger, Andrew A Maudsley, et al.
Frontiers in Bioscience : a Journal and Virtual Library|February 24, 2004
Elevated expression of IFN-gamma in the HIV-1 infected brainPaul Shapshak, Robert Duncan, Alireza Minagar, et al.
Thescientificworldjournal|August 28, 2018
Microglia and Astrocytes in Neuro-Aids, Alzheimers Disease, and Multiple SclerosisAlireza Minagar, Paul Shapshak, Melvin Heyes, et al.
Pageof 6